Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride.

Author: AndrewsElizabeth B, Cainzos-AchiricaMiguel, FlynnRobert W V, FortunyJoan, Garcia-RodriguezLuis, GilsenanAlicia, MacDonaldThomas M, PlanaEstel, RuigómezAna, ZiemieckiRyan

Paper Details 
Original Abstract of the Article :
A multinational post-authorization safety study assessed cardiovascular safety in initiators of prucalopride for chronic constipation compared with a matched cohort of polyethylene glycol 3350 initiators. The primary safety outcome was major adverse cardiovascular events (MACE), a composite of hospi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053159/

データ提供:米国国立医学図書館(NLM)

Validating Cardiovascular Safety: A Multi-database Approach in a Post-authorization Safety Study

The desert of drug safety research is vast and complex, requiring meticulous exploration to ensure the well-being of patients. This study, like a seasoned caravan, navigated the vast landscape of multiple databases to assess the cardiovascular safety of [prucalopride], a medication used for chronic constipation. The researchers focused on [major adverse cardiovascular events (MACE)], a crucial indicator of heart health. Their mission involved validating the accuracy of data sources from the United Kingdom, ensuring that the information used to assess drug safety was reliable and trustworthy. This meticulous approach is essential in ensuring the safety and efficacy of medications.

Building Trust in Drug Safety

This study underscores the importance of thorough data validation in drug safety research. By meticulously examining the accuracy of multiple databases, researchers contribute to building trust in the safety profile of medications. This process is crucial in navigating the vast desert of drug development and ensuring the well-being of patients.

Navigating the Desert of Drug Safety

This study exemplifies the careful, deliberate approach required in drug safety research. It's like navigating a vast desert, carefully verifying every source of information to ensure a safe and reliable path. Understanding the intricacies of drug safety is crucial for both medical professionals and patients, allowing us to navigate the desert of potential side effects with confidence.

Dr. Camel's Conclusion

This study reminds us that navigating the desert of drug safety research requires a meticulous approach. Every step taken, every data point validated, brings us closer to ensuring the safety and well-being of patients. By meticulously analyzing and verifying information, we can build trust in the medications we use, ensuring a safe journey through the desert of healthcare.

Date :
  1. Date Completed 2022-04-20
  2. Date Revised 2022-04-20
Further Info :

Pubmed ID

33606202

DOI: Digital Object Identifier

PMC8053159

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.